Binay seeks probe into deaths linked to unauthorized use of IV gluta
Sen. Nancy Binay (Voltaire Domingo and Joseph Vidal / Senate Social Media Unit)
MANILA, Philippines — A resolution seeking probe on the reported deaths linked to the unauthorized use of intravenous (IV) glutathione has been filed in the Senate.
Senator Nancy Binay, who has faced discrimination due to her skin color, filed proposed Senate Resolution No. 952.
This development transpired not long after actress Mariel Rodriguez-Padilla’s controversial IV drip session in the Senate, which was also questioned by Binay being the chairperson of the Senate committee on ethics.
In her resolution, Binay cited Health Secretary Ted Herbosa’s pronouncement that IV glutathione is not safe to be used in clinics and is rather designed for hospitals.
Binay particularly noted that despite repeated warnings by the Philippine government, the use of injectable glutathione for beauty enhancement and skin treatment continues to be endorsed by public figures.
“It is necessary that the government continuously implement measures to prevent unauthorized use of IV glutathione and remind the public to: (1) consult only board-certified dermatologists; (2) avoid buying intravenous or injectable products online; and (3) avoid being lured to a promising effect of medicines as beauty products,” said Binay.
“It is the duty of the Senate to inquire on the unauthorized use of IV glutathione to ensure the safety and to protect the health of the public by policy or by law,” she emphasized.
